Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Adams

Showing results (541-550 of 3,026) with videos related to

Pageof 303
Sort By:
British Journal of Haematology|December 22, 2017
Post-ABVD biopsy results, and not post-ABVD FDG-PET results, predict outcome in early-stage Hodgkin lymphomaHugo J A Adams, Thomas C Kwee
The New England Journal of Medicine|September 8, 2016
Interim PET-CT Scan in Advanced Hodgkin's LymphomaHugo J A Adams, Thomas C Kwee
Annals of Hematology|September 9, 2016
No convincing evidence to support postinduction FDG-PET in follicular lymphomaHugo J A Adams, Thomas C Kwee
Seminars in Oncology|June 25, 2018
An evidence-based review on the value of interim FDG-PET in assessing response to therapy in lymphomaHugo J A Adams, Thomas C Kwee
Blood|June 3, 2018
Benefit of brentuximab over bleomycin in first-line treatment of advanced-stage Hodgkin lymphoma has not been provenHugo J A Adams, Thomas C Kwee
Journal of Abnormal Psychology|December 1, 1981
The effects of presleep stress on sleep-onset insomniaS N Haynes, A Adams, M Franzen
Tree Physiology|July 10, 2010
Woody legumes: a (re)view from the SouthMark A Adams, Judy Simon, Sebastian Pfautsch
Journal of Osteoporosis|October 29, 2010
Vertebroplasty and Kyphoplasty Can Restore Normal Spine Mechanics following Osteoporotic Vertebral FractureJin Luo, Michael A Adams, Patricia Dolan
Nuclear Medicine Communications|August 9, 2016
Does interim 18F-FDG-PET response-adapted therapy really benefit advanced-stage Hodgkin lymphoma patients?Hugo J A Adams, Thomas C Kwee
Journal of the National Comprehensive Cancer Network : JNCCN|March 11, 2018
Letter to the Editor: No Evidence to Promote Interim FDG-PET Adapted Therapy in the NCCN Guidelines for Hodgkin LymphomaHugo J A Adams, Thomas C Kwee,
Pageof 303

Showing results (541-550 of 3,026) with videos related to

Sort By:
Pageof 303
British Journal of Haematology|December 22, 2017
Post-ABVD biopsy results, and not post-ABVD FDG-PET results, predict outcome in early-stage Hodgkin lymphomaHugo J A Adams, Thomas C Kwee
The New England Journal of Medicine|September 8, 2016
Interim PET-CT Scan in Advanced Hodgkin's LymphomaHugo J A Adams, Thomas C Kwee
Annals of Hematology|September 9, 2016
No convincing evidence to support postinduction FDG-PET in follicular lymphomaHugo J A Adams, Thomas C Kwee
Seminars in Oncology|June 25, 2018
An evidence-based review on the value of interim FDG-PET in assessing response to therapy in lymphomaHugo J A Adams, Thomas C Kwee
Blood|June 3, 2018
Benefit of brentuximab over bleomycin in first-line treatment of advanced-stage Hodgkin lymphoma has not been provenHugo J A Adams, Thomas C Kwee
Journal of Abnormal Psychology|December 1, 1981
The effects of presleep stress on sleep-onset insomniaS N Haynes, A Adams, M Franzen
Tree Physiology|July 10, 2010
Woody legumes: a (re)view from the SouthMark A Adams, Judy Simon, Sebastian Pfautsch
Journal of Osteoporosis|October 29, 2010
Vertebroplasty and Kyphoplasty Can Restore Normal Spine Mechanics following Osteoporotic Vertebral FractureJin Luo, Michael A Adams, Patricia Dolan
Nuclear Medicine Communications|August 9, 2016
Does interim 18F-FDG-PET response-adapted therapy really benefit advanced-stage Hodgkin lymphoma patients?Hugo J A Adams, Thomas C Kwee
Journal of the National Comprehensive Cancer Network : JNCCN|March 11, 2018
Letter to the Editor: No Evidence to Promote Interim FDG-PET Adapted Therapy in the NCCN Guidelines for Hodgkin LymphomaHugo J A Adams, Thomas C Kwee,
Pageof 303